- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07728305
Relative Age and Passing Performance in Pre-adolescent Football Players (RAE-LSPT)
Relative Age and Passing Performance in Pre-adolescent Football Players: A Cross-Sectional Study Using the Loughborough Soccer Passing Test
Studie Overzicht
Toestand
Conditie
Gedetailleerde beschrijving
Annual age grouping in youth football can create a relative age effect, characterised by the over-representation of players born earlier in the selection year. This pattern is often attributed to temporary developmental advantages, but it is unclear whether earlier-born pre-adolescent players also demonstrate superior technical performance.
The study used a cross-sectional observational design in a youth football development programme in Bello, Colombia. The source cohort contained 61 participant records. Birth month was used to classify players into four relative-age quarters: Q1 (January-March), Q2 (April-June), Q3 (July-September) and Q4 (October-December), and into two semesters: H1 (January-June) and H2 (July-December).
Passing performance was measured with the Loughborough Soccer Passing Test. Players were scheduled to complete two trials separated by five minutes. Each trial comprised 16 externally cued passes to four colour-coded target areas. Movement time was adjusted by adding penalties for inaccurate execution or protocol violations and subtracting bonuses for striking the central target strip. Lower total performance time indicated better performance. The primary technical outcome was the mean total performance time across available trials. Sensitivity outcomes included Trial 1 and the best trial.
The primary analysis estimated the association between birth month and LSPT total performance time after adjustment for birth cohort. Additional analyses examined representation by quarter and semester and agreement between the two LSPT trials. Data collection was completed in 2017. The study is being registered retrospectively in 2026 to improve transparency and support public sharing of the anonymised dataset and analysis materials.
Studietype
Inschrijving (Werkelijk)
Contacten en locaties
Studie Locaties
-
-
Antioquia
-
Guarne, Antioquia, Colombia, 054080
- Tecnológico de Antioquia
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Kind
Accepteert gezonde vrijwilligers
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
- Registered or actively participating in the selected youth football development programme in Bello, Colombia during the assessment period.
- Date of birth available in the programme roster.
- Able to undertake the football passing assessment.
- Written parent or legal guardian consent and child assent.
Exclusion Criteria:
- Acute injury, illness or medical restriction preventing safe completion of the LSPT [retain only if this was an actual criterion].
- Unable to complete the required familiarisation or test procedure.
- Missing date-of-birth information.
- No valid LSPT trial available for inclusion in the primary analytical sample.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Cohorten en interventies
Groep / Cohort |
|---|
|
Group 1
Q1 - Players born from January to March
|
|
Group 2
Q2 - Players born from April to June
|
|
Group 3
Q3 - Players born from July to September
|
|
Group 4
Q4 - Players born from October to December
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Mean LSPT total performance time
Tijdsspanne: Day 1
|
Mean of all available LSPT trial total performance times, expressed in seconds.
For each trial, total performance time was calculated as movement time plus penalty time minus bonus time.
Lower values indicate better performance.
|
Day 1
|
|
Number of participants in each relative-age quarter
Tijdsspanne: Baseline
|
Count of participants classified as Q1 (January-March), Q2 (April-June), Q3 (July-September) or Q4 (October-December), based on the date of birth recorded in the programme roster.
|
Baseline
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
LSPT Trial 1 total performance time
Tijdsspanne: Day 1
|
Trial 1 movement time plus penalty time minus bonus time, expressed in seconds.
|
Day 1
|
|
Best LSPT total performance time
Tijdsspanne: Day 1
|
Lowest total performance time recorded across the participant's available LSPT trials, expressed in seconds.
Two trials were scheduled five minutes apart.
|
Day 1
|
|
Number of participants in each relative-age semester
Tijdsspanne: Baseline
|
Count of participants classified as H1 (January-June) or H2 (July-December), based on the date of birth recorded in the programme roster.
|
Baseline
|
|
Difference between Trial 2 and Trial 1 total performance time
Tijdsspanne: Day 1
|
Trial 2 total performance time minus Trial 1 total performance time, expressed in seconds, among participants who completed both trials.
The two trials were scheduled five minutes apart.
|
Day 1
|
Medewerkers en onderzoekers
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- RAE-LSPT-2017-01
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
IPD-tijdsbestek voor delen
IPD-toegangscriteria voor delen
IPD delen Ondersteunend informatietype
- LEERPROTOCOOL
- SAP
- ANALYTIC_CODE
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .